Project Bidof - Monovision by Pairing Bifocal and EDOF Lens (Bidof)

March 5, 2024 updated by: Matthias Bolz, Johannes Kepler University of Linz

Project Bidof - Achieving Hybrid Monovision by Pairing Bifocal and EDOF Lens Technology

Modern day cataract surgery isn't just a rehabilitative procedure anymore but rather aims at improving a patient's quality of life by reducing the need for spectacles in everyday life to a minimum. One way of achieving this goal is by using different lens technologies, such as a mono- or bifocal lens paired a lens with EDOF technology, as EDOF lenses provide an enhanced depth of focus by creating a single elongated focal point. As this method is well established, the aim of this study is to compare the monofocal/EDOF cohort to the bifocal/EDOF cohort and evaluate visual acuity and patient satisfaction for both combinations.

Study Overview

Status

Withdrawn

Conditions

Study Type

Observational

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Upper Austria
      • Linz, Upper Austria, Austria, 4020
        • Johannes Kepler University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years to 99 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Patient between 21 and 99 years after cataract surgery

Description

Inclusion Criteria:

  • Age between 21 and 99 years
  • signed informed consent form
  • condition after cataract surgery

Exclusion Criteria:

  • no signed informed consent form
  • laser treatment of the Cornea
  • macular pathologies
  • corneal pathologies
  • irregular astigmatism
  • pregnancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Other
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Monodof
monofocal and EDOF lens
Bidof
Bifocal and EDOF lens

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Distance Visual Acuity
Time Frame: 6 months
percentage of patients with binocular distance corrected visual acuity of logMAR > 0.2
6 months
Intermediate Visual Acuity
Time Frame: 6 months
percentage of patients with binocular intermediate distance corrected visual acuity of logMAR > 0.2
6 months
Near Visual Acuity
Time Frame: 6 months
percentage of patients with binocular near visual acuity logmar < 0.2
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
contrast vision
Time Frame: 3 months
contrast sensitivity vision
3 months
Halo and Glare
Time Frame: 3 months
Halo and Glare Simulator
3 months
Defocus curve
Time Frame: 3 and 6 months
Defocus curve
3 and 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 14, 2022

Primary Completion (Actual)

March 14, 2023

Study Completion (Actual)

March 14, 2023

Study Registration Dates

First Submitted

March 22, 2022

First Submitted That Met QC Criteria

March 22, 2022

First Posted (Actual)

March 31, 2022

Study Record Updates

Last Update Posted (Actual)

March 7, 2024

Last Update Submitted That Met QC Criteria

March 5, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • KUK-Ophthalmology-005

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cataract Senile

Subscribe